[HTML][HTML] Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas
HS Ngu, KJ Savage - Haematologica, 2023 - ncbi.nlm.nih.gov
Peripheral T-cell lymphomas (PTCL) encompass over 30 different entities and although they
share post-thymic T-or NK-cell derivation, the disease biology and genomic landscape are …
share post-thymic T-or NK-cell derivation, the disease biology and genomic landscape are …
Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma
Angioimmunoblastic T cell lymphoma (AITL) is a common subtype of mature peripheral T
cell lymphoma (PTCL). As per the 2016 World Health Organization classification, AITL is …
cell lymphoma (PTCL). As per the 2016 World Health Organization classification, AITL is …
T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology
SM Horwitz, S Ansell, WZ Ai, J Barnes, SK Barta… - Journal of the National …, 2022 - jnccn.org
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative
disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas …
disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas …
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
M Hamadani, M Ngoya, A Sureda, Q Bashir… - Blood …, 2022 - ashpublications.org
Mature T-cell lymphomas constitute the most common indication for allogeneic
hematopoietic cell transplantation (allo-HCT) of all lymphomas. Large studies evaluating …
hematopoietic cell transplantation (allo-HCT) of all lymphomas. Large studies evaluating …
Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant
Importance Reduced-intensity conditioning and nonmyeloablative conditioning (RIC-NMAC)
regimens are frequently used in allogeneic hematopoietic cell transplant (HCT) for non …
regimens are frequently used in allogeneic hematopoietic cell transplant (HCT) for non …
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de …
Background Peripheral T cell lymphomas form a heterogeneous group with a usually dismal
prognostic. The place of allogeneic stem cell transplantation to treat PTCL is debated …
prognostic. The place of allogeneic stem cell transplantation to treat PTCL is debated …
Peripheral T-cell lymphomas: therapeutic approaches
D Sibon - Cancers, 2022 - mdpi.com
Simple Summary Peripheral T-cell lymphomas are a group of rare cancers of T cells or
natural killer cells, most often with a poor prognosis. In recent years, significant progress has …
natural killer cells, most often with a poor prognosis. In recent years, significant progress has …
Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
SCF Couto, A Kowes, CS Aurabi, TGM Oliveira… - Frontiers in …, 2023 - frontiersin.org
Peripheral T cell lymphoma (PTCL) is a rare and aggressive type of non-Hodgkin's
lymphoma that affects mature T cells. This type of cancer is characterized by the abnormal …
lymphoma that affects mature T cells. This type of cancer is characterized by the abnormal …
Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma …
There have been no large studies comparing reduced‐intensity/non‐myeloablative
conditioning (RIC/NMA) to myeloablative conditioning (MAC) regimens in T‐cell non …
conditioning (RIC/NMA) to myeloablative conditioning (MAC) regimens in T‐cell non …
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Peripheral T cell lymphoma (PTCL) represents a group of heterogeneous hematological
malignancies, which are notoriously challenging to treat and outcomes are typically poor …
malignancies, which are notoriously challenging to treat and outcomes are typically poor …